QT Vascular in US$13.14m convertible debt investment to fund growth

QT Vascular, a developer of minimally invasive products for the treatment of vascular diseases, has entered into a US$13.14 million convertible debt investment to fund its next growth phase.

This comes less than a month after the company entered into a US$12 million convertible bond investment to further develop its Drug-Coated Chocolate platform.

On Friday, the counter closed down 0.84 per cent, or 0.1 Singapore cent, at S$0.118.